Atlas.
Sign inStart free trial
IARTNASDAQ · US

INTEGRA LIFESCIENCES HOLDINGS CORP

Technology · Surgical & Medical Instruments & Apparatus

TechnologySurgical & Medical Instruments & Apparatus
CEO
—
Founded
—
IPO Date
—
HQ
Princeton, NJ, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$17.89 ▲ 49.0%
Last (1 Jul 2026) · $18
Period High · $18.76
Period Low · $8.90
52W: $8.90 – $18.76

Key Metrics

Share Price
$17.89
-0.4% today
Market Cap
$1.4B
P / E
—
EV / Revenue
1.2x
Revenue Growth
+1.5%
year-on-year
Gross Margin
—
Enterprise Value
$1.9B
52W High
$18.76
52W Low
$8.90
Avg Volume
972K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
11 known institutional holders·$241M total on record·2026-Q1
BlackRock, Inc.
13.2%·$97M
Invesco Ltd.
4.5%·$33M
State Street Corp
3.7%·$27M
Dimensional Fund Advisors LP
3.6%·$26M
Goldman Sachs Group Inc
2.4%·$18M
Geode Capital Management, LLC
2.1%·$16M
Bank Of America Corp
1.8%·$13M
Northern Trust Corp
1.0%·$7M
Jpmorgan Chase & Co
0.5%·$4M
Price T Rowe Associates Inc
0.1%·$741
Fmr LLC
0.0%·$45,931
Free Float
67.1%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for INTEGRA LIFESCIENCES HOLDINGS CORP
OverviewINTEGRA LIFESCIENCES HOLDINGS CORP share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow INTEGRA LIFESCIENCES HOLDINGS CORP generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsINTEGRA LIFESCIENCES HOLDINGS CORP's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityINTEGRA LIFESCIENCES HOLDINGS CORP executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsINTEGRA LIFESCIENCES HOLDINGS CORP's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for INTEGRA LIFESCIENCES HOLDINGS CORP, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for INTEGRA LIFESCIENCES HOLDINGS CORP aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersINTEGRA LIFESCIENCES HOLDINGS CORP valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for INTEGRA LIFESCIENCES HOLDINGS CORP with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for INTEGRA LIFESCIENCES HOLDINGS CORP — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial